Cite
A real-world analysis of FDA Adverse Event Reporting System (FAERS) events for liposomal and conventional doxorubicins
MLA
Huiling Su, et al. “A Real-World Analysis of FDA Adverse Event Reporting System (FAERS) Events for Liposomal and Conventional Doxorubicins.” Scientific Reports, vol. 14, no. 1, Mar. 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1038/s41598-024-55185-4.
APA
Huiling Su, Jing Jia, Yuxiang Mao, Riran Zhu, & Zhengjun Li. (2024). A real-world analysis of FDA Adverse Event Reporting System (FAERS) events for liposomal and conventional doxorubicins. Scientific Reports, 14(1), 1–12. https://doi.org/10.1038/s41598-024-55185-4
Chicago
Huiling Su, Jing Jia, Yuxiang Mao, Riran Zhu, and Zhengjun Li. 2024. “A Real-World Analysis of FDA Adverse Event Reporting System (FAERS) Events for Liposomal and Conventional Doxorubicins.” Scientific Reports 14 (1): 1–12. doi:10.1038/s41598-024-55185-4.